Agent Capital

Brace Pharma Capital invests in companies developing therapies for diseases with unmet medical needs.

Averin Capital invests in companies applying breakthrough technologies to human health.

Clal Biotechnology Industries invests in and supports biotechnology companies developing treatments and technologies for unmet medical needs.

BioRock Ventures invests in early-stage biotechnology companies developing therapeutic medicines.

Avant Bio invests in companies developing technologies and services that enable therapeutic innovation.

Nextech Invest invests in emerging biotechnology companies developing cancer treatments.